U.S. flag

An official website of the United States government

NM_130468.4(CHST14):c.453dup (p.Cys152fs) AND Ehlers-Danlos syndrome, musculocontractural type 1

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 8, 2017
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000515454.1

Allele description [Variation Report for NM_130468.4(CHST14):c.453dup (p.Cys152fs)]

NM_130468.4(CHST14):c.453dup (p.Cys152fs)

Gene:
CHST14:carbohydrate sulfotransferase 14 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
15q15.1
Genomic location:
Preferred name:
NM_130468.4(CHST14):c.453dup (p.Cys152fs)
HGVS:
  • NC_000015.10:g.40471666dup
  • NG_017074.1:g.5706dup
  • NM_130468.4:c.453dupMANE SELECT
  • NP_569735.1:p.Cys152fs
  • LRG_600:g.5706dup
  • NC_000015.9:g.40763865dup
  • NM_130468.2:c.453dup
Protein change:
C152fs
Links:
OMIM: 608429.0010; dbSNP: rs1555410747
NCBI 1000 Genomes Browser:
rs1555410747
Molecular consequence:
  • NM_130468.4:c.453dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Ehlers-Danlos syndrome, musculocontractural type 1
Identifiers:
MONDO: MONDO:0020681; MedGen: CN295219; OMIM: 601776

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000611541OMIM
no assertion criteria provided
Pathogenic
(Nov 8, 2017)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Ehlers-Danlos syndrome in two siblings with deficient lysyl hydroxylase activity in cultured skin fibroblasts but only mild hydroxylysine deficit in skin.

Steinmann B, Gitzelmann R, Vogel A, Grant ME, Harwood R, Sear CH.

Helv Paediatr Acta. 1975 Oct;30(3):255-74.

PubMed [citation]
PMID:
1184396

The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations.

Janecke AR, Li B, Boehm M, Krabichler B, Rohrbach M, Müller T, Fuchs I, Golas G, Katagiri Y, Ziegler SG, Gahl WA, Wilnai Y, Zoppi N, Geller HM, Giunta C, Slavotinek A, Steinmann B.

Am J Med Genet A. 2016 Jan;170A(1):103-15. doi: 10.1002/ajmg.a.37383. Epub 2015 Sep 16.

PubMed [citation]
PMID:
26373698
PMCID:
PMC5115638

Details of each submission

From OMIM, SCV000611541.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In a Pakistani sister and brother with the musculocontractural type of Ehlers-Danlos syndrome (EDSMC1; 601776), originally reported by Steinmann et al. (1975), Janecke et al. (2015) identified homozygosity for a duplication (c.453dup) in the CHST14 gene, causing a frameshift predicted to result in a premature termination codon (CYS152LeufsTer10). The unaffected parents were heterozygous for the mutation. Cultured dermal fibroblasts from the patients showed lack of a reticular extracellular matrix (ECM) of fibronectin (FN1; 135600) and tenascins (see 187380), and the level of tenascins was markedly reduced compared with control fibroblasts. Patient fibroblasts lacked decorin (DCN; 125255) and thrombospondin (see 188060) fibrils in the extracellular environment, and lacked the fibronectin and fibrillar collagen receptors alpha-5-beta-1 (ITGB1; 135630) and alpha-2-beta-1 (ITGA2; 192974), respectively, on the cell surface. Mutant cells showed intracellular retention of collagen types I (see 120150) and III (see 120180), and reduced deposition of collagen types I, III, V (see 120215), and VI (see 120220) fibrils in the ECM, compared to controls; mutant cells also produced and stored higher amounts of chondroitin sulfate glycosaminoglycans in the cytoplasm, which was not organized in the ECM.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022